Tucson VA Medical Center Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management

Go back to Tucson VA Medical Center Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management

Omnicell (OMCL) PT Raised to $155 at Cantor Fitzgerald

November 2, 2021 11:38 AM EDT

Cantor Fitzgerald analyst Steven Halper raised the price target on Omnicell (NASDAQ: OMCL) to $155.00 (from $135.00) while maintaining a Neutral rating.

The analyst commented, "We reiterate our Neutral rating on OMCL shares but increase our 12-month, DCF-based price target to $155 (compared to $135 previously). This morning, November 2, the company reported 3Q21 results that were ahead of our estimates and FactSet consensus. Revenue was $296 million compared to our estimate of $284 million. Revenue... More